{"date":"2026-11-06","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4147-2026-11-06-0801-wnyrxd","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-11-06","time":"08:01:34","subject":"中裕新藥榮獲 BioTech Breakthrough Awards「年度感染疾病創新獎」以創新抗體藥物研發成果榮獲國際生技產業肯定","clause":"第53款","fact_date":"2026-11-06","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-11-06 08:01，「中裕新藥榮獲 BioTech Breakthrough Awards「年度感染疾病創新獎」以創新抗體藥物研發成果榮獲國際」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}